Cargando…

Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is common in severe coronavirus disease 2019 (COVID-19) and worsens the prognosis. Sildenafil, a phosphodiesterase-5 inhibitor, is approved for PAH treatment but little is known about its efficacy in cases of severe COVID-19 with PAH. This study aimed to investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliynyk, Oleksandr Valentynovych, Rorat, Marta, Strepetova, Olena Vadymivna, Dubrov, Serhij Oleksandrovych, Guryanov, Vitaliy Grygorovych, Oliynyk, Yanina Volodymyrivna, Kulivets, Oleksii Serhijovych, Ślifirczyk, Anna, Barg, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223625/ https://www.ncbi.nlm.nih.gov/pubmed/37243243 http://dx.doi.org/10.3390/v15051157

Ejemplares similares

Impact of Alteplase on Mortality in Critically Ill Patients with COVID-19 and Pulmonary Embolism
por: Oliynyk, Oleksandr Valentynovych, et al.
Publicado: (2023)

Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy
por: Oliynyk, Oleksandr, et al.
Publicado: (2021)

Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants
por: Oliynyk, Oleksandr, et al.
Publicado: (2022)

Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome
por: Oliynyk, Oleksandr, et al.
Publicado: (2021)

Oxygen metabolism markers as predictors of mortality in severe COVID-19
por: Oliynyk, Oleksandr V., et al.
Publicado: (2021)

Age-related late-onset disease heritability patterns and implications for genome-wide association studies
por: Oliynyk, Roman Teo
Publicado: (2019)

Quantifying the Potential for Future Gene Therapy to Lower Lifetime Risk of Polygenic Late-Onset Diseases
por: Oliynyk, Roman Teo
Publicado: (2019)

Evaluating the Potential of Younger Cases and Older Controls Cohorts to Improve Discovery Power in Genome-Wide Association Studies of Late-Onset Diseases
por: Oliynyk, Roman Teo
Publicado: (2019)

Future Preventive Gene Therapy of Polygenic Diseases from a Population Genetics Perspective
por: Oliynyk, Roman Teo
Publicado: (2019)

Human-caused wolf mortality persists for years after discontinuation of hunting
por: Oliynyk, Roman Teo
Publicado: (2023)

Author Correction: Human-caused wolf mortality persists for years after discontinuation of hunting
por: Oliynyk, Roman Teo
Publicado: (2023)

Actoprotective effect of ginseng: improving mental and physical performance
por: Oliynyk, Sergiy, et al.
Publicado: (2013)

The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance
por: Oliynyk, Sergiy, et al.
Publicado: (2012)

Hypoxia modeling techniques: A review
por: Salyha, Nataliya, et al.
Publicado: (2023)

Specimen Size Effect on the Tensile Properties of Rolled Steel of Long-Term-Operated Portal Crane
por: Zvirko, Olha, et al.
Publicado: (2023)

A Silent Killer: Left Main Coronary Artery Disease in Gastrointestinal Bleed
por: Afify, Hesham, et al.
Publicado: (2021)

Efficient modification and preparation of circular DNA for expression in cell culture
por: Oliynyk, Roman Teo, et al.
Publicado: (2022)

Sildenafil in the treatment of pulmonary hypertension
por: Barnett, Christopher F, et al.
Publicado: (2006)

Sildenafil in pediatric pulmonary arterial hypertension
por: Dhariwal, AK, et al.
Publicado: (2015)

The hypertensive effect of sorafenib is abolished by sildenafil
por: Dabiré, Hubert, et al.
Publicado: (2020)

Pharmacokinetic and Pharmacodynamic Comparison of Sildenafil‐Bosentan and Sildenafil‐Ambrisentan Combination Therapies for Pulmonary Hypertension
por: Hakamata, A, et al.
Publicado: (2016)

Automatic online spike sorting with singular value decomposition and fuzzy C-mean clustering
por: Oliynyk, Andriy, et al.
Publicado: (2012)

Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN)
por: Vijay Kumar, J.R., et al.
Publicado: (2021)

Real-time clinician text feeds from electronic health records
por: Teo, James T. H., et al.
Publicado: (2021)

Novel Tautomerisation Mechanisms of the Biologically Important Conformers of the Reverse Löwdin, Hoogsteen, and Reverse Hoogsteen G(*)·C(*) DNA Base Pairs via Proton Transfer: A Quantum-Mechanical Survey
por: Brovarets', Ol'ha O., et al.
Publicado: (2019)

Hard and Transparent Films Formed by Nanocellulose–TiO(2) Nanoparticle Hybrids
por: Schütz, Christina, et al.
Publicado: (2012)

Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension
por: YOSHIYUKI, Rieko, et al.
Publicado: (2016)

Is Sildenafil an Effective Therapy in the Management of Persistent Pulmonary Hypertension?
por: Yaseen, Hakam, et al.
Publicado: (2012)

Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension
por: Chinello, Pierangelo, et al.
Publicado: (2011)

Sildenafil in endotoxin-induced pulmonary hypertension: an experimental study
por: Kemper, Daniella Aparecida Godoi, et al.
Publicado: (2021)

Electromagnetic Properties of Carbon Nanotube/BaFe(12−x)Ga(x)O(19)/Epoxy Composites with Random and Oriented Filler Distributions
por: Yakovenko, Olena S., et al.
Publicado: (2021)

Administration of Glucosylceramide Ameliorated the Memory Impairment in Aged Mice
por: Lee, Yeonju, et al.
Publicado: (2013)

Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
por: Keogh, Anne M, et al.
Publicado: (2008)

Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010)

Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
por: Ramani, Gautam V, et al.
Publicado: (2010)

Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients
por: Siehr, Stephanie L., et al.
Publicado: (2015)

Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia
por: Lilyasari, Oktavia, et al.
Publicado: (2019)

Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis
por: van der Graaf, Marisa, et al.
Publicado: (2019)

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
por: Ghofrani, Hossein A., et al.
Publicado: (2006)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
por: Tang, Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sufgc6ovb8lg299rieo9u97rmk